INTICA SYSTEMS SE (IS7.DE) Stock Fundamental Analysis
FRA:IS7 - Deutsche Boerse Ag - DE0005874846 - Common Stock - Currency: EUR
Overall IS7 gets a fundamental rating of 2 out of 10. We evaluated IS7 against 52 industry peers in the Electronic Equipment, Instruments & Components industry. IS7 may be in some trouble as it scores bad on both profitability and health. IS7 is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year IS7 has reported negative net income.
IS7 had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: IS7 reported negative net income in multiple years.
Each year in the past 5 years IS7 had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -5.05%, IS7 is doing worse than 69.23% of the companies in the same industry.
IS7's Return On Equity of -18.79% is on the low side compared to the rest of the industry. IS7 is outperformed by 69.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.05% | ||
| ROE | -18.79% | ||
| ROIC | N/A |
ROA(3y)-1.02%
ROA(5y)0.02%
ROE(3y)-3.67%
ROE(5y)-0.35%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Operating Margin of IS7 has declined.
With a decent Gross Margin value of 44.03%, IS7 is doing good in the industry, outperforming 63.46% of the companies in the same industry.
In the last couple of years the Gross Margin of IS7 has remained more or less at the same level.
IS7 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.03% |
OM growth 3Y-45.56%
OM growth 5Y-27.46%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.66%
GM growth 5Y1.46%
2. Health
2.1 Basic Checks
IS7 does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IS7 has about the same amount of shares outstanding.
The number of shares outstanding for IS7 remains at a similar level compared to 5 years ago.
IS7 has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.01, we must say that IS7 is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of IS7 (1.01) is worse than 78.85% of its industry peers.
The Debt to FCF ratio of IS7 is 13.05, which is on the high side as it means it would take IS7, 13.05 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 13.05, IS7 is in line with its industry, outperforming 46.15% of the companies in the same industry.
A Debt/Equity ratio of 0.38 indicates that IS7 is not too dependend on debt financing.
IS7 has a Debt to Equity ratio of 0.38. This is comparable to the rest of the industry: IS7 outperforms 51.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 13.05 | ||
| Altman-Z | 1.01 |
ROIC/WACCN/A
WACC6.02%
2.3 Liquidity
A Current Ratio of 0.90 indicates that IS7 may have some problems paying its short term obligations.
The Current ratio of IS7 (0.90) is worse than 88.46% of its industry peers.
IS7 has a Quick Ratio of 0.90. This is a bad value and indicates that IS7 is not financially healthy enough and could expect problems in meeting its short term obligations.
IS7's Quick ratio of 0.48 is on the low side compared to the rest of the industry. IS7 is outperformed by 86.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.9 | ||
| Quick Ratio | 0.48 |
3. Growth
3.1 Past
IS7 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -125.17%.
IS7 shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -18.72%.
Measured over the past years, IS7 shows a small growth in Revenue. The Revenue has been growing by 1.44% on average per year.
EPS 1Y (TTM)-125.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1050%
Revenue 1Y (TTM)-18.72%
Revenue growth 3Y-9.65%
Revenue growth 5Y1.44%
Sales Q2Q%-14.86%
3.2 Future
The Earnings Per Share is expected to grow by 42.93% on average over the next years. This is a very strong growth
Based on estimates for the next years, IS7 will show a small growth in Revenue. The Revenue will grow by 5.92% on average per year.
EPS Next Y54.29%
EPS Next 2Y42.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.36%
Revenue Next 2Y5.92%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for IS7. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 70.30, the valuation of IS7 can be described as expensive.
61.54% of the companies in the same industry are cheaper than IS7, based on the Price/Forward Earnings ratio.
IS7 is valuated expensively when we compare the Price/Forward Earnings ratio to 36.71, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 70.3 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IS7 indicates a somewhat cheap valuation: IS7 is cheaper than 69.23% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, IS7 is valued cheaper than 90.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.02 | ||
| EV/EBITDA | 6.55 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as IS7's earnings are expected to grow with 42.93% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.93%
EPS Next 3YN/A
5. Dividend
5.1 Amount
IS7 does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:IS7 (7/16/2025, 7:00:00 PM)
2.13
0 (0%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners60.42%
Ins Owner ChangeN/A
Market Cap9.14M
Analysts45.71
Price Target3.88 (82.16%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-13.64%
PT rev (3m)-24%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 70.3 | ||
| P/S | 0.14 | ||
| P/FCF | 4.02 | ||
| P/OCF | 1.9 | ||
| P/B | 0.54 | ||
| P/tB | 0.77 | ||
| EV/EBITDA | 6.55 |
EPS(TTM)-0.76
EYN/A
EPS(NY)0.03
Fwd EY1.42%
FCF(TTM)0.53
FCFY24.9%
OCF(TTM)1.12
OCFY52.5%
SpS15.76
BVpS3.94
TBVpS2.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.05% | ||
| ROE | -18.79% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.03% | ||
| FCFM | 3.36% |
ROA(3y)-1.02%
ROA(5y)0.02%
ROE(3y)-3.67%
ROE(5y)-0.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.7%
ROCE(5y)3.73%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-45.56%
OM growth 5Y-27.46%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.66%
GM growth 5Y1.46%
F-Score4
Asset Turnover1.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 13.05 | ||
| Debt/EBITDA | 1.23 | ||
| Cap/Depr | 38.1% | ||
| Cap/Sales | 3.73% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 92.8% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.9 | ||
| Quick Ratio | 0.48 | ||
| Altman-Z | 1.01 |
F-Score4
WACC6.02%
ROIC/WACCN/A
Cap/Depr(3y)103.63%
Cap/Depr(5y)82.04%
Cap/Sales(3y)7.51%
Cap/Sales(5y)5.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-125.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1050%
EPS Next Y54.29%
EPS Next 2Y42.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.72%
Revenue growth 3Y-9.65%
Revenue growth 5Y1.44%
Sales Q2Q%-14.86%
Revenue Next Year3.36%
Revenue Next 2Y5.92%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5474.07%
EBIT growth 3Y-50.82%
EBIT growth 5Y-26.41%
EBIT Next Year1216.67%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y147.89%
FCF growth 3YN/A
FCF growth 5Y-9.62%
OCF growth 1Y1.52%
OCF growth 3Y29.25%
OCF growth 5Y-6.33%